Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders? - Ian B. Hickie; Allan H. Young; F. Markus Leweke (Research Directions Depression, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com